Syngene International Limited
SYNGENE.NS
Get informed when a big investor buys or sells
+ FollowMarket Cap$139.83B
Close$
$628.25
60.9% upside
Current Fair Value
60.9% upsideUndervalued by 60.9% based on the discounted cash flow analysis.
Share Statistics
| Market cap | $139.83 Billion |
|---|---|
| Enterprise Value | - |
| Dividend Yield | $1.25 (0.36%) |
| Earnings per Share | $7.87 |
| Beta | 0.08 |
| Outstanding Shares | 402,503,158 |
Return
| Return on Equity | NaN% |
|---|---|
| Return on Assets | NaN% |
| Return on Invested Capital | NaN% |
Valuation & Multiples
| P/E Ratio | 63.16 |
|---|---|
| PEG | -57.22 |
| Price to Sales | 4.39 |
| Price to Book Ratio | - |
| Enterprise Value to Revenue | - |
| Enterprise Value to EBIT | - |
| Enterprise Value to Net Income | - |
| Total Debt to Enterprise | - |
| Debt to Equity | - |
Revenue Sources
No data
Insider Trades
Last Earnings Call
Report Date
July 29, 2026
EPS Estimate
$1.45
Average shareholder expectationRevenue Estimate
$8.56 B
Average shareholder expectationNext Earnings Call
Expected Date
October 27, 2026
EPS Estimate
$1.00
Average shareholder expectationRevenue Estimate
$8.23 B
Average shareholder expectationInstitutional Sentiment (Put/Call)
No data available for the latest quarter.
Institutional Ownership
No data available for the latest quarter.
ESG Score
No data
About Syngene International Limited
6,692 employees
CEO: Siddharth Mittal Syngene International Limited, established in 1993 and based in Bengaluru, India, functions as a prominent contract research and manufacturing organization (CRAMO). As a subsidiary of Biocon Limited, Syngene extends its comprehensive dru...